Goodwill of VBI Vaccines Inc/BC from 06 May 2016 to 31 Mar 2024

Taxonomy & unit
us-gaap: USD
Description
Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.
Summary
VBI Vaccines Inc/BC quarterly Goodwill in USD history and change rate from 06 May 2016 to 31 Mar 2024.
  • VBI Vaccines Inc/BC Goodwill for the quarter ending 31 Mar 2024 was $1,107,000, a 48% decline year-over-year.
Source SEC data
View on sec.gov
Goodwill, Quarterly (USD)
Goodwill, YoY Quarterly Change (%)

VBI Vaccines Inc/BC Quarterly Goodwill (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q1 2024 $1,107,000 -$1,025,000 -48% 31 Mar 2024 10-Q 15 May 2024 2024 Q1
Q4 2023 $1,130,000 -$997,000 -47% 31 Dec 2023 10-Q 15 May 2024 2024 Q1
Q3 2023 $2,121,000 +$17,000 +0.81% 30 Sep 2023 10-Q 14 Nov 2023 2023 Q3
Q2 2023 $2,175,000 -$62,000 -2.8% 30 Jun 2023 10-Q 14 Aug 2023 2023 Q2
Q1 2023 $2,132,000 -$171,000 -7.4% 31 Mar 2023 10-Q 15 May 2023 2023 Q1
Q4 2022 $2,127,000 -$134,000 -5.9% 31 Dec 2022 10-K 16 Apr 2024 2023 FY
Q3 2022 $2,104,000 -$159,000 -7% 30 Sep 2022 10-Q 10 Nov 2022 2022 Q3
Q2 2022 $2,237,000 -$88,000 -3.8% 30 Jun 2022 10-Q 08 Aug 2022 2022 Q2
Q1 2022 $2,303,000 +$20,000 +0.88% 31 Mar 2022 10-Q 09 May 2022 2022 Q1
Q4 2021 $2,261,000 $0 0% 31 Dec 2021 10-K 13 Mar 2023 2022 FY
Q3 2021 $2,263,000 +$111,000 +5.2% 30 Sep 2021 10-Q 08 Nov 2021 2021 Q3
Q2 2021 $2,325,000 +$216,000 +10% 30 Jun 2021 10-Q 02 Aug 2021 2021 Q2
Q1 2021 $2,283,000 +$251,000 +12% 31 Mar 2021 10-Q 10 May 2021 2021 Q1
Q4 2020 $2,261,000 +$53,000 +2.4% 31 Dec 2020 10-K 07 Mar 2022 2021 FY
Q3 2020 $2,152,000 -$25,000 -1.1% 30 Sep 2020 10-Q 02 Nov 2020 2020 Q3
Q2 2020 $2,109,000 -$6,491,000 -75% 30 Jun 2020 10-Q 31 Jul 2020 2020 Q2
Q1 2020 $2,032,000 -$6,406,000 -76% 31 Mar 2020 10-Q 06 May 2020 2020 Q1
Q4 2019 $2,208,000 -$6,057,000 -73% 31 Dec 2019 10-K 02 Mar 2021 2020 FY
Q3 2019 $2,177,000 -$6,550,000 -75% 30 Sep 2019 10-Q 06 Nov 2019 2019 Q3
Q2 2019 $8,600,000 +$39,000 +0.46% 30 Jun 2019 10-Q 09 Aug 2019 2019 Q2
Q1 2019 $8,438,000 -$293,000 -3.4% 31 Mar 2019 10-Q 01 May 2019 2019 Q1
Q4 2018 $8,265,000 -$709,000 -7.9% 31 Dec 2018 10-K 05 Mar 2020 2019 FY
Q3 2018 $8,727,000 -$294,000 -3.3% 30 Sep 2018 10-Q 09 Nov 2018 2018 Q3
Q2 2018 $8,561,000 -$111,000 -1.3% 30 Jun 2018 10-Q 26 Jul 2018 2018 Q2
Q1 2018 $8,731,000 +$281,000 +3.3% 31 Mar 2018 10-Q 01 May 2018 2018 Q1
Q4 2017 $8,974,000 +$589,000 +7% 31 Dec 2017 10-K 25 Feb 2019 2018 FY
Q3 2017 $9,021,000 30 Sep 2017 10-Q 13 Nov 2017 2017 Q3
Q2 2017 $8,672,000 30 Jun 2017 10-Q 31 Jul 2017 2017 Q2
Q1 2017 $8,450,000 -$264,000 -3% 31 Mar 2017 10-Q 15 May 2017 2017 Q1
Q4 2016 $8,385,000 31 Dec 2016 10-K 26 Feb 2018 2017 FY
Q1 2016 $8,714,000 06 May 2016 10-K 26 Feb 2018 2017 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.